Advertisement

Sperm Binding to the Zona Pellucida, Hyaluronic Acid Binding Assay, and PICSI

Chapter

Abstract

Work derived from the IVF arena has demonstrated that an abnormal sperm–zona pellucida interaction is frequently observed in infertile men. Such finding can be observed in the presence of normal or abnormal “basic” sperm parameters. An impaired sperm–zona pellucida interaction can result in failure of fertilization, thereby, decreasing chances of pregnancy when couples are being subjected to intrauterine insemination (IUI) or conventional IVF therapies. Consequently, sperm–zona pellucida binding assays were developed as a real need to assess sperm functional competence in the “extended” evaluation of the infertility work-up. The sperm Hyaluronic Binding Acid (HBA) assay has been applied to select sperm for ICSI. It has been proposed that the results of the test indicate that the selected spermatozoa have undergone normal spermatogenesis, but more studies are needed to prove its clinical value.

Keywords

Hyaluronic Acid Zona Pellucida Acrosome Reaction Human Oocyte Intrauterine Insemination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Oehninger S. Clinical management of male infertility in assisted reproduction: ICSI and beyond. Int J Androl. 2011;34(5 Pt 2):e319–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Nagy ZP, Liu J, Joris H, Verheyen G, Tournaye H, Camus M, Derde MC, Devroey P, Van Steirteghem AC. The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod. 1995;10(5):1123–9.PubMedGoogle Scholar
  3. 3.
    Oehninger S, Veeck L, Lanzendorf S, Maloney M, Toner J, Muasher S. Intracytoplasmic sperm injection: achievement of high pregnancy rates in couples with severe male factor infertility is dependent primarily upon female and not male factors. Fertil Steril. 1995;64(5):977–81.PubMedGoogle Scholar
  4. 4.
    Aitken RJ, De Iuliis GN. Origins and consequences of DNA damage in male germ cells. Reprod Biomed Online. 2007;14(6):727–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control (CDC), American Society for Reproductive Medicine & Society for Assisted Reproductive Technology. 2007 Assisted Reproductive Technology Success Rates. Atlanta, GA: US Department of Health and Human Services, CDC; 2009.Google Scholar
  6. 6.
    Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, Nygren KG. European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod. 2009;24(6):1267–87.PubMedCrossRefGoogle Scholar
  7. 7.
    Barroso G, Valdespin C, Vega E, Kershenovich R, Avila R, Avendaño C, Oehninger S. Developmental sperm contributions: fertilization and beyond. Fertil Steril. 2009;92(3):835–48.PubMedCrossRefGoogle Scholar
  8. 8.
    Burkman LJ, Coddington CC, Franken DR, Krugen TF, Rosenwaks Z, Hogen GD. The hemizona assay: development of a diagnostic test for the binding of human spermatozoa to the human zona pellucida to predict fertilization potential. Fertil Steril. 1988;49(4):688–97.PubMedGoogle Scholar
  9. 9.
    Liu DY, Lopata A, Johnston WI, Baker HW. A human sperm-zona pellucida binding test using oocytes that failed to fertilize in vitro. Fertil Steril. 1988;50(5):782–8.PubMedGoogle Scholar
  10. 10.
    ESHRE Andrology Special Interest Group. Consensus workshop on advanced diagnostic andrology techniques. Hum Reprod. 1996;11(7):1463–79.CrossRefGoogle Scholar
  11. 11.
    World Health Organization (WHO). WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 5th ed. UK: WHO Cambridge University Press; 2010. p. 31–3.Google Scholar
  12. 12.
    Oehninger S, Franken D, Kruger T. Approaching the next millennium: how should we manage andrology diagnosis in the intracytoplasmic sperm injection era? Fertil Steril. 1997;67(3):434–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Arslan M, Morshedi M, Arslan EO, Taylor S, Kanik A, Duran HE, Oehninger S. Predictive value of the hemizona assay for pregnancy outcome in patients undergoing controlled ovarian hyperstimulation with intrauterine insemination. Fertil Steril. 2006;85(6):1697–707.PubMedCrossRefGoogle Scholar
  14. 14.
    Huszar G, Willetts M, Corrales M. Hyaluronic acid (Sperm Select) improves retention of sperm motility and velocity in normospermic and oligospermic specimens. Fertil Steril. 1990;54(6):1127–34.PubMedGoogle Scholar
  15. 15.
    Huszar G, Jakab A, Sakkas D, Ozenci CC, Cayli S, Delpiano E, Ozkavukcu S. Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects. Reprod Biomed Online. 2007;14(5):650–63.PubMedCrossRefGoogle Scholar
  16. 16.
    Overstreet JW, Hembree WC. Penetration of the zona pellucida of nonliving human oocytes by human spermatozoa in vitro. Reprod Biomed Online. 2007;14(5):650–63.CrossRefGoogle Scholar
  17. 17.
    Yanagimachi R, Lopata A, Odom CB, Bronson RA, Mahi CA, Nicolson GL. Retention of biologic characteristics of zona pellucida in highly concentrated salt solution: the use of salt-stored eggs for assessing the fertilizing capacity of spermatozoa. Fertil Steril. 1979;31(5):562–74.PubMedGoogle Scholar
  18. 18.
    Oehninger S, Morshedi M, Franken D. The hemizona assay for assessment of sperm function. Methods Mol Biol. 2013;927:91–102.PubMedCrossRefGoogle Scholar
  19. 19.
    Oehninger S, Franken D, Alexander N, Hodgen GD. Hemizona assay and its impact on the identification and treatment of human sperm dysfunctions. Andrologia. 1992;24(6):307–21.PubMedCrossRefGoogle Scholar
  20. 20.
    Oehninger S, Mahony M, Ozgur K, Kolm P, Kruger T, Franken D. Clinical significance of human sperm-zona pellucida binding. Fertil Steril. 1997;67(6):1121–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Franken DR, Kruger TF, Oehninger S, Coddington CC, Lombard C, Smith K, Hodgen GD. The ability of the hemizona assay to predict human fertilization in different and consecutive in-vitro fertilization cycles. Hum Reprod. 1993;8(8):1240–4.PubMedGoogle Scholar
  22. 22.
    Oehninger S, Scott RT, Coddington CC, Franken DR, Acosta AA, Hodgen GD. Validation of the hemizona assay in a monkey model: influence of oocyte maturational stages. Fertil Steril. 1989;51(5):881–5.PubMedGoogle Scholar
  23. 23.
    Oehninger S, Morshedi M, Ertunc H, Philput C, Bocca SM, Acosta AA, Hodgen GD. Validation of the hemizona assay (HZA) in a monkey model. II Kinetics of binding and influence of cryopreserved-thawed spermatozoa. J Assist Reprod Genet. 1993;10(4):292–301.PubMedCrossRefGoogle Scholar
  24. 24.
    Franken DR, Oosthuizen WT, Cooper S, Kruger TF, Burkman LJ, Coddington CC, Hodgen GD. Electron microscopic evidence on the acrosomal status of bound sperm and their penetration into human hemizonae pellucida after storage in a buffered salt solution. Andrologia. 1991;23(3):205–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Oehninger S, Coddington CC, Scott R, Franken DA, Burkman LJ, Acosta AA, Hodgen GD. Hemizona assay: assessment of sperm dysfunction and prediction of in vitro fertilization outcome. Fertil Steril. 1989;51(4):665–70.PubMedGoogle Scholar
  26. 26.
    Franken DR, Oehninger S, Burkman LJ, Coddington CC, Kruger TF, Rosenwaks Z, Acosta AA, Hodgen GD. The hemizona assay (HZA): a predictor of human sperm fertilizing potential in in vitro fertilization (IVF) treatment. J In Vitro Fertil Embryo Transf. 1989;6(1):44–50.CrossRefGoogle Scholar
  27. 27.
    Oehninger S, Franken D, Kruger T, Toner JP, Acosta AA, Hodgen GD. Hemizona assay: sperm defect analysis, a diagnostic method for assessment of human sperm-oocyte interactions, and predictive value for fertilization outcome. Ann N Y Acad Sci. 1991;626:111–24.PubMedCrossRefGoogle Scholar
  28. 28.
    Liu DY. Could using the zona pellucida bound sperm for intracytoplasmic sperm injection (ICSI) enhance the outcome of ICSI? Asian J Androl. 2011;13(2):197–8.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Casciani V, Minasi MG, Fabozzi G, Scarselli F, Colasante A, Lobascio AM, Greco E. Traditional intracytoplasmic sperm injection provides equivalent outcomes compared with human zona pellucida-bound selected sperm injection. Zygote. 2013;9:1–6.CrossRefGoogle Scholar
  30. 30.
    Oehninger S, Franken DR, Sayed E, Barroso G, Kolm P. Sperm function assays and their predictive value for fertilization outcome in IVF therapy: a meta-analysis. Hum Reprod Update. 2000;6(2):160–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Slotte H, Akerlof E, Pousette A. Separation of human spermatozoa with hyaluronic acid induces, and Percoll inhibits, the acrosome reaction. Int J Androl. 1993;16(6):349–54.PubMedCrossRefGoogle Scholar
  32. 32.
    Huszar G, Ozenci CC, Cayli S, Zavaczki Z, Hansch E, Vigue L. Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. Fertil Steril. 2003;79 Suppl 3:1616–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Russell DL, Salustri A. Extracellular matrix of the cumulus-oocyte complex. Semin Reprod Med. 2006;24(4):217–27.PubMedCrossRefGoogle Scholar
  34. 34.
    Kogan G, Soltes L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett. 2007;29(1):17–25.PubMedCrossRefGoogle Scholar
  35. 35.
    Chung MK, Chiu PC, Lee CL, Pang RT, Ng EH, Lee KF, Koistinen R, Koistinen H, Seppala M, Yeung WS. Cumulus-associated alpha2-macroglobulin derivative retains proconceptive glycodelin-C in the human cumulus matrix. Hum Reprod. 2009;24(11):2856–67.PubMedCrossRefGoogle Scholar
  36. 36.
    Ranganathan S, Ganguly AK, Datta K. Evidence for presence of hyaluronan binding protein on spermatozoa and its possible involvement in sperm function. Mol Reprod Dev. 1994;38(1):69–76.PubMedCrossRefGoogle Scholar
  37. 37.
    Hunnicutt GR, Primakoff P, Myles DG. Sperm surface protein PH-20 is bifunctional: one activity is a hyaluronidase and a second, distinct activity is required in secondary sperm-zona binding. Biol Reprod. 1996;55(1):80–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Hunnicutt GR, Mahan K, Lathrop WF, Ramarao CS, Myles DG, Primakoff P. Structural relationship of sperm soluble hyaluronidase to the sperm membrane protein PH-20. Biol Reprod. 1996;54(6):1343–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Sabeur K, Cherr GN, Yudin AI, Overstreet JW. Hyaluronic acid enhances induction of the acrosome reaction of human sperm through interaction with the PH-20 protein. Zygote. 1998;6(2):103–11.PubMedCrossRefGoogle Scholar
  40. 40.
    Ghosh I, Chattopadhaya R, Kumar V, Chakravarty BN, Datta K. Hyaluronan binding protein-1: a modulator of sperm-oocyte interaction. Soc Reprod Fertil Suppl. 2007;63:539–43.PubMedGoogle Scholar
  41. 41.
    Jakab A, Sakkas D, Delpiano E, Cayli S, Kovanci E, Ward D, Revelli A, Huszar G. Intracytoplasmic sperm injection: a novel selection method for sperm with normal frequency of chromosomal aneuploidies. Fertil Steril. 2005;84(6):1665–73.PubMedCrossRefGoogle Scholar
  42. 42.
    Cayli S, Jakab A, Ovari L, Delpiano E, Celik-Ozenci C, Sakkas D, Ward D, Huszar G. Biochemical markers of sperm function: male fertility and sperm selection for ICSI. Reprod Biomed Online. 2003;7(4):462–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Cayli S, Sakkas D, Vigue L, Demir R, Huszar G. Cellular maturity and apoptosis in human sperm: creatine kinase, caspase-3 and Bcl-XL levels in mature and diminished maturity sperm. Mol Hum Reprod. 2004;10(5):365–72.PubMedCrossRefGoogle Scholar
  44. 44.
    Parmegiani L, Cognigni GE, Bernardi S, Troilo E, Ciampaglia W, Filicori M. “Physiologic ICSI”: hyaluronic acid (HA) favors selection of spermatozoa without DNA fragmentation and with normal nucleus, resulting in improvement of embryo quality. Fertil Steril. 2010;93(2):598–604.PubMedCrossRefGoogle Scholar
  45. 45.
    Worrilow KC, Eid S, Matthews J, Pelts E, Khoury C, Liebermann J. Multi-site clinical trial evaluating PICSI, a method for selection of hyaluronan bound sperm (HBS) for use in ICSI: improved clinical outcomes. Hum Reprod. 2010;25 Suppl 1:6–9.Google Scholar
  46. 46.
    Worrilow KC, Eid S, Woodhouse D, Perloe M, Smith S, Witmyer J, Ivani K, Khoury C, Ball GD, Elliot T, Lieberman J. Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes–multicenter, double-blinded and randomized controlled trial. Hum Reprod. 2013;28(2):306–14.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Tarozzi N, Nadalini M, Bizzaro D, Serrao L, Fava L, Scaravelli G, Borini A. Sperm-hyaluronan-binding assay: clinical value in conventional IVF under Italian law. Reprod Biomed Online. 2009;19 Suppl 3:35–43.PubMedCrossRefGoogle Scholar
  48. 48.
  49. 49.
  50. 50.
    Van Den Bergh MJ, F-DM HMK. Pronuclear zygote score following intracytoplasmic injection of hyaluronan-bound spermatozoa: a prospective randomized study. Reprod Biomed Online. 2009;19(6):796–801.CrossRefGoogle Scholar
  51. 51.
    Menezo Y, Junca A, Dumont-Hassan M, De Mouzon J, Cohen-Bacrie P, Ben KM. “Physiologic” (hyaluronic acid-carried) ICSI results in the same embryo quality and pregnancy rates as with the use of potentially toxic polyvinylpyrrolidone (PVP). Fertil Steril. 2010;93(5):S232.CrossRefGoogle Scholar
  52. 52.
    Menezo Y, Nicollet B. Replacement of PVP by hyaluronate (SpermSlow) in ICSI—impact on outcome. IFFS Abstract of 18th World Congress on Fertilityand Sterility 2004. 23–28 May 2004, Montreal, Canada.Google Scholar
  53. 53.
    Nasr-Esfahani MH, Razavi S, Vahdati AA, Fathi F, Tavalaee M. Evaluation of sperm selection procedure based on hyaluronic acid binding ability on ICSI outcome. J Assist Reprod Genet. 2008;25(5):197–203.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Strehler E, Baccetti B, Sterzik K, Capitani S, Collodel G, De Santo M, et al. Detrimental effects of polyvinylpyrrolidone on the ultrastructure of spermatozoa (Notulae seminologicae 13). Hum Reprod. 1998;13(1):120–3.PubMedCrossRefGoogle Scholar
  55. 55.
    Ye H, Huang GN, Gao Y, de Liu Y. Relationship between human sperm-hyaluronan binding assay and fertilization rate in conventional in vitro fertilization. Hum Reprod. 2006;21(6):1545–50.PubMedCrossRefGoogle Scholar
  56. 56.
    Nijs M, Creemers E, Cox A, Franssen K, Janssen M, Vanheusden E, De Jonge C, Ombelet W. Chromomycin A3 staining, sperm chromatin structure assay and hyaluronic acid binding assay as predictors for assisted reproductive outcome. Reprod Biomed Online. 2009;19(5):671–6984.PubMedCrossRefGoogle Scholar
  57. 57.
    Petersen CG, Massaro FC, Mauri AL, Oliveira JB, Baruffi RL, Franco Jr JG. Efficacy of hyaluronic acid binding assay in selecting motile spermatozoa with normal morphology at high magnification. Reprod Biol Endocrinol. 2010;8:149.PubMedCentralPubMedCrossRefGoogle Scholar
  58. 58.
    Kovacs P, Kovats T, Sajgo A, Szollosi J, Matyas S, Kaali SG. The role of hyaluronic acid binding assay in choosing the fertilization method for patients undergoing IVF for unexplained infertility. J Assist Reprod Genet. 2011;28(1):49–54.PubMedCentralPubMedCrossRefGoogle Scholar
  59. 59.
    Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppala M, Ho PC, Chiu PC. Roles of glycodelin in modulating sperm function. Mol Cell Endocrinol. 2006;250(1–2):149–56.PubMedCrossRefGoogle Scholar
  60. 60.
    Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppala M, Chiu PC. Effects of glycodelins on functional competence of spermatozoa. J Reprod Immunol. 2009;83(1–2):26–30.PubMedCrossRefGoogle Scholar
  61. 61.
    Dong KW, Chi TF, Juan YW, Chen CW, Lin Z, Xiang XQ, Mahony M, Gibbons WE, Oehninger S. Characterization of the biologic activities of a recombinant human zona pellucida protein 3 expressed in human ovarian teratocarcinoma (PA-1) cells. Am J Obstet Gynecol. 2001;184(5):835–43.PubMedCrossRefGoogle Scholar
  62. 62.
    Henkel R. Sperm preparation: state-of-the-art—physiological aspects and application of advanced sperm preparation methods. Asian J Androl. 2012;14(2):260–9.PubMedCentralPubMedCrossRefGoogle Scholar
  63. 63.
    Gronwald W, Huber F, Grünewald P, Spörner M, Wohlgemuth S, Herrmann C, Kalbitzer HR. Solution structure of the Ras binding domain of the protein kinase Byr2 from Schizosaccharomyces pombe. Structure. 2001;9(11):1029–41.PubMedCrossRefGoogle Scholar
  64. 64.
    Hoogendijk CF, Kruger TF, Bouic PJ, Henkel RR. A novel approach for the selection of human sperm using annexin V-binding and flow cytometry. Fertil Steril. 2009;91(4):1285–92.PubMedCrossRefGoogle Scholar
  65. 65.
    Chan PJ, Jacobson JD, Corselli JU, Patton WC. A simple zeta method for sperm selection based on membrane charge. Fertil Steril. 2006;85(2):481–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Ainsworth C, Nixon B, Aitken RJ. Development of a novel electrophoretic system for the isolation of human spermatozoa. Hum Reprod. 2005;20(8):2261–70.PubMedCrossRefGoogle Scholar
  67. 67.
    Bartoov B, Berkovitz A, Eltes F. Selection of spermatozoa with normal nuclei to improve the pregnancy rate with intracytoplasmic sperm injection. N Engl J Med. 2001;345(14):1067–8.PubMedCrossRefGoogle Scholar
  68. 68.
    Bartoov B, Berkovitz A, Eltes F, Kogosovsky A, Yagoda A, Lederman H, Artzi S, Gross M, Barak Y. Pregnancy rates are higher with intracytoplasmic morphologically selected sperm injection than with conventional intracytoplasmic injection. Fertil Steril. 2003;80(6):1413–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Berkovitz A, Eltes F, Ellenbogen A, Peer S, Feldberg D, Bartoov B. Does the presence of nuclear vacuoles in human sperm selected for ICSI affect pregnancy outcome? Hum Reprod. 2006;21(7):1787–90.PubMedCrossRefGoogle Scholar
  70. 70.
    Berkovitz A, Eltes F, Lederman H, Peer S, Ellenbogen A, Feldberg B, Bartoov B. How to improve IVF-ICSI outcome by sperm selection. Reprod Biomed Online. 2006;12(5):634–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Klement AH, Koren-Morag N, Itsykson P, Berkovitz A. Intracytoplasmic morphologically selected sperm injection versus intracytoplasmic sperm injection: a step toward a clinical algorithm. Fertil Steril. 2013;99(5):1290–3.PubMedCrossRefGoogle Scholar
  72. 72.
    Garolla A, Fortini D, Menegazzo M, De Toni L, Nicoletti V, Moretti A, Selice R, Engl B, Foresta C. High-power microscopy for selecting spermatozoa for ICSI by physiological status. Reprod Biomed Online. 2008;17(5):610–6.PubMedCrossRefGoogle Scholar
  73. 73.
    Huser T, Orme CA, Hollars CW, Corzett MH, Balhorn R. Raman spectroscopy of DNA packaging in individual human sperm cells distinguishes normal from abnormal cells. J Biophotonics. 2009;2(5):322–32.PubMedCrossRefGoogle Scholar
  74. 74.
    Gianaroli L, Magli MC, Ferraretti AP, Crippa A, Lappi M, Capitani S, Baccetti B. Birefringence characteristics in sperm heads allow for the selection of reacted spermatozoa for intracytoplasmic sperm injection. Fertil Steril. 2010;93(3):807–13.PubMedCrossRefGoogle Scholar
  75. 75.
    Avendaño C, Oehninger S. DNA fragmentation in morphologically normal spermatozoa: how much should we be concerned in the ICSI era? J Androl. 2011;32(4):356–63.PubMedCrossRefGoogle Scholar
  76. 76.
    Avendaño C, Franchi A, Duran H, Oehninger S. DNA fragmentation of normal spermatozoa negatively impacts embryo quality and intracytoplasmic sperm injection outcome. Fertil Steril. 2010;94(2):549–57.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, The Jones Institute for Reproductive MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations